Search Results

There are 45173 results for: content related to: RENAL CELL CARCINOMA: WHAT DOES THE FUTURE HOLD?

  1. Targeted therapy for advanced renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Chris Coppin, Lyly Le, Timothy J Wilt and Christian Kollmannsberger

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006017.pub2

  2. You have free access to this content
    Adverse events from targeted therapies in advanced renal cell carcinoma: the impact on long-term use

    BJU International

    Volume 107, Issue 11, June 2011, Pages: 1722–1732, Ziya Kirkali

    Article first published online : 20 JAN 2011, DOI: 10.1111/j.1464-410X.2010.09985.x

  3. You have free access to this content
    Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan

    International Journal of Urology

    Volume 19, Issue 4, April 2012, Pages: 284–295, Yoshihiro Wada, Wataru Takahashi, Yoshiaki Kawano and Masatoshi Eto

    Article first published online : 27 MAR 2012, DOI: 10.1111/j.1442-2042.2012.02962.x

  4. You have free access to this content
    Optimal management of metastatic renal cell carcinoma: an algorithm for treatment

    BJU International

    Volume 104, Issue 1, July 2009, Pages: 10–18, Joaquim Bellmunt, Per Flodgren, Jan Roigas and Stéphane Oudard

    Article first published online : 21 APR 2009, DOI: 10.1111/j.1464-410X.2009.08563.x

  5. You have free access to this content
    Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

    BJU International

    Volume 108, Issue 10, November 2011, Pages: 1556–1563, Chris Coppin, Christian Kollmannsberger, Lyly Le, Franz Porzsolt and Timothy J. Wilt

    Article first published online : 27 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10629.x

  6. You have free access to this content
    Current management and future perspectives of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 21, Issue 9, September 2014, Pages: 847–855, Richard Lee-Ying, Renee Lester and Daniel YC Heng

    Article first published online : 27 MAY 2014, DOI: 10.1111/iju.12502

  7. You have free access to this content
    Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation

    BJU International

    Volume 112, Issue 2, July 2013, Pages: E211–E220, Iori Sakai, Hideaki Miyake and Masato Fujisawa

    Article first published online : 10 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11655.x

  8. You have free access to this content
    Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Article first published online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  9. You have free access to this content
    Recent advances in molecular targeted therapy for metastatic renal cell carcinoma

    International Journal of Urology

    Volume 16, Issue 5, May 2009, Pages: 444–448, Yoichi Mizutani

    Article first published online : 3 MAR 2009, DOI: 10.1111/j.1442-2042.2009.02277.x

  10. You have full text access to this OnlineOpen article
    New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1486–1497, Mark Agulnik

    Article first published online : 11 AUG 2011, DOI: 10.1002/cncr.26361

  11. You have free access to this content
    Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms

    BJU International

    Volume 104, Issue 11, December 2009, Pages: 1585–1589, Peter Mulders

    Article first published online : 10 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08987.x

  12. You have free access to this content
    Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

    BJU International

    Volume 108, Issue 8b, October 2011, Pages: E250–E257, Camillo Porta, Giuseppe Procopio, Giacomo Cartenì, Roberto Sabbatini, Alessandra Bearz, Isabella Chiappino, Enzo Maria Ruggeri, Giovanni Lo Re, Riccardo Ricotta, Fable Zustovich, Lorenza Landi, Anna Calcagno, Ilaria Imarisio, Elena Verzoni, Mimma Rizzo, Chiara Paglino, Valentina Guadalupi and Emilio Bajetta

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10186.x

  13. You have free access to this content
    Recent advances in the treatment of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 20, Issue 10, October 2013, Pages: 944–955, Hideyuki Abe and Takao Kamai

    Article first published online : 21 MAY 2013, DOI: 10.1111/iju.12187

  14. You have free access to this content
    Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

    Value in Health

    Volume 13, Issue 1, January/February 2010, Pages: 61–68, Martin Hoyle, Colin Green, Jo Thompson-Coon, Zulian Liu, Karen Welch, Tiffany Moxham and Ken Stein

    Article first published online : 25 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00617.x

  15. You have free access to this content
    New systemic treatment options for metastatic renal-cell carcinoma in the era of targeted therapies

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 1, March 2010, Pages: 5–18, Thean Hsiang TAN, Ganesalingam PRANAVAN, Hodo Z HAXHIMOLLA and Desmond YIP

    Article first published online : 8 MAR 2010, DOI: 10.1111/j.1743-7563.2010.01277.x

  16. You have free access to this content
    Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

    BJU International

    Volume 108, Issue 5, September 2011, Pages: 665–672, Ágnes Benedict, Robert A. Figlin, Per Sandström, Ulrika Harmenberg, Anders Ullén, Claudie Charbonneau, Rickard Sandin, Edit Remák, Subramanian Hariharan and Sylvie Négrier

    Article first published online : 25 JAN 2011, DOI: 10.1111/j.1464-410X.2010.09957.x

  17. Pharmacokinetic Profile of Temsirolimus With Concomitant Administration of Cytochrome P450-Inducing Medications

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1430–1439, Joseph Boni, Cathie Leister, Jaime Burns, Maria Cincotta, Bruce Hug and Laurence Moore

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007306957

  18. You have free access to this content
    Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma

    Cancer

    Volume 115, Issue 16, 15 August 2009, Pages: 3618–3630, Anil Kapoor and Robert A. Figlin

    Article first published online : 28 MAY 2009, DOI: 10.1002/cncr.24409

  19. You have free access to this content
    Sunitinib-related interstitial pneumonia after treatment with temsirolimus: A case of possible recall phenomenon

    International Journal of Urology

    Volume 21, Issue 4, April 2014, Pages: 420–421, Hisako Kushima, Hiroshi Ishii and Jun-ichi Kadota

    Article first published online : 29 OCT 2013, DOI: 10.1111/iju.12332

  20. You have free access to this content
    Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer

    International Journal of Cancer

    Volume 126, Issue 6, 15 March 2010, Pages: 1327–1338, Sharad S. Singhal, Archana Sehrawat, Mukesh Sahu, Preeti Singhal, Rit Vatsyayan, Poorna Chandra Rao Lelsani, Sushma Yadav and Sanjay Awasthi

    Article first published online : 22 JUL 2009, DOI: 10.1002/ijc.24767